HemaCare, a supplier of human-derived biological products and services for biomedical research, drug discovery, and cellular therapy process development, has moved its global headquarters to Northridge, in a move that the company says more than doubles its donor collection capacity and on-site cell processing capabilities. The company, which was previously based in Van Nuys, says its new facility is at the 44-acre Harman Campus. HemaCare's President and CEO is Pete van der Wal. The company has been talking about making the move since July of 2017.
More Headlines
